Prelude Capital Management’s Daseke, Inc. Common Stock DSKE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-295,996
Closed -$2.46M 1592
2024
Q1
$2.46M Buy
295,996
+280,117
+1,764% +$2.29M 0.13% 192
2023
Q4
$129K Sell
15,879
-5,355
-25% -$25.9K 0.01% 1006
2023
Q3
$109K Buy
+21,234
New +$128K 0.01% 984
2019
Q3
Sell
-9,674
Closed -$35K 2158
2019
Q2
$35K Sell
9,674
-35,326
-79% -$167K ﹤0.01% 1201
2019
Q1
$229K Buy
+45,000
New +$203K 0.01% 676
2018
Q4
Sell
-61,455
Closed -$493K 2247
2018
Q3
$493K Sell
61,455
-153,700
-71% -$1.37M 0.03% 530
2018
Q2
$2.14M Buy
215,155
+24,750
+13% +$230K 0.14% 142
2018
Q1
$1.86M Buy
190,405
+17,053
+10% +$204K 0.14% 133
2017
Q4
$2.48M Sell
173,352
-6,541
-4% -$87.6K 0.2% 100
2017
Q3
$2.35M Sell
179,893
-103,206
-36% -$1.29M 0.21% 104
2017
Q2
$3.15M Buy
283,099
+35,608
+14% +$354K 0.3% 67
2017
Q1
$2.5M Buy
247,491
+214,883
+659% +$2.17M 0.24% 98
2016
Q4
$329K Buy
+32,608
New +$322K 0.04% 412

Prelude Capital Management's DSKE Position: Q2 2024 in Review

Prelude Capital Management sold out of Daseke, Inc. Common Stock (DSKE) in Q2 2024, closing a stake of 295,996 shares — an estimated $2.46M sold.

Prelude Capital Management first reported a position in DSKE in Q4 2016 and held it in 13 quarters. The position peaked at $3.15M in Q2 2017. 0 funds tracked by Wall St. Rank hold DSKE as of Q2 2024.

  • Prelude Capital Management reported no remaining Daseke, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Prelude Capital Management sold 295,996 Daseke, Inc. Common Stock shares in Q2 2024, an estimated $2.46M.
  • Prelude Capital Management first reported a position in Daseke, Inc. Common Stock in Q4 2016 and held it in 13 quarters.
  • Prelude Capital Management's Daseke, Inc. Common Stock position peaked at $3.15M in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Daseke, Inc. Common Stock as of Q2 2024.

Based on Prelude Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.